Skip to the page

Data / Form D filings / ILIAD BIOTECHNOLOGIES, INC.

ILIAD BIOTECHNOLOGIES, INC.: Form D filing

ILIAD BIOTECHNOLOGIES, INC., a biotechnology company in Weston, FL, filed a Form D with the SEC in 2026. The latest, on February 20, 2026, reports $115.5 million sold of a $115.5 million offering to 36 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4581 WESTON ROAD SUITE 260, Weston, FL, 33331
Phone
(800) 603-3525
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2112659

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 20, 2026New notice$115,540,057$115,540,05736Feb 5, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Keith RubinExecutive Officer, Director
Mario BarroDirector
Avi NaiderDirector
Eric EdidinDirector
William SteinkraussExecutive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Feb 16, 2026 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ILIAD BIOTECHNOLOGIES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.